-
-
-
-
-
-
-
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies
-
-
-
-
-
-
-
Catalyst Pharmaceuticals Reports Record Second Quarter and First Half 2025 Financial Results; Provides Business Update
-
-
-
-
-
-
-
Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Santhera Announces Half-Year 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
-
-
-
-
-
-
-
Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update
-
-
-
-
-
-
-
Catalyst Pharmaceuticals Acquires Exclusive North American License For Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
-
1,199,636 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

